BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines

Leukemia. 2014 May;28(5):1145-8. doi: 10.1038/leu.2013.377. Epub 2013 Dec 17.

¹ Department of Pharmacology & Experimental Therapeutics, The Center for Cancer Research, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA.
² 1] Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA [2] Department of Haematology, University College London Cancer Institute, University College London, London, UK.
³ Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
⁴ Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
⁵ Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.
⁶ Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA.

No abstract available

Publication types